Cancel

Data-Driven Decisions in Crohn's Disease: Positioning Patients for Success

While there is a tendency for clinicians to rely on one approach to treating Crohn's disease (CD), making confident data-driven treatment decisions in moderate-to-severe CD is imperative for durable, long-term remission. The traditional approach that has been based on progressive, step-wise treatment intensification with re-evaluation of response according to symptoms does not improve long-term outcomes in CD and increases risk for bowel damage. However, the introduction of treat-to-target (T2...
CME Outfitters

Embracing Biosimilars in IBD: How Can We Leverage Them in Our Practice?

Target Audience This educational activity is directed toward gastroenterologists, primary care clinicians, nurse practitioners, physician assistants, and other health care professionals involved in the management of inflammatory bowel disease (IBD). Activity Overview Biosimilars are biologic products that are highly similar to a previously approved reference (or originator) biologic drugs in terms of safety, purity, and potency (ie, efficacy). Biosimilars first entered United States r...
Physicians’ Education Resource®, LLC.

3rd Annual Virtual Medical Crossfire® in IBS and IBD

Target Audience This educational activity is directed toward gastroenterologists and primary care physicians. Nurse practitioners, physician assistants, pharmacists, researchers, and other health care professionals involved in the treatment and management of IBS and IBD are also invited to participate. Activity Overview Much of the substantial morbidity, mortality, and cost associated with chronic gastrointestinal disorders, including irritable bowel syndrome (IBS) and inflammatory bo...
Physicians’ Education Resource®, LLC.

Optimizing Care in Inflammatory Bowel Disease (IBD): The Role of Emerging Therapies in Improving Patient Outcomes

Target Audience This educational activity is directed toward gastroenterologists, primary care clinicians, nurse practitioners, physician assistants, and other health care professionals involved in the treatment of patients with IBD. Activity Overview Although biologic agents helped usher in a new treatment paradigm for inflammatory bowel disease (IBD), appreciable rates of primary non-response, loss of response, and adverse reactions still require additional treatments. Clinical rese...
Physicians’ Education Resource®, LLC.

CORE Higher Education Group, CESearchEngine.com, and our advertising partners do not endorse and do not verify the accuracy of the content in the activities presented on the CESearchEngine.com website or within our mobile apps.CORE Higher Education Group, CESearchEngine.com, and our advertising partners are not responsible for errors, omissions, or misrepresentations contained within activities presented on the CESearchEngine website or within our mobile apps. For complete details, please read the CESearchEngine.com Terms of Service. Site Map